Xtant Medical Statistics Share Statistics Xtant Medical has 139.32M
shares outstanding. The number of shares has increased by 0.44%
in one year.
Shares Outstanding 139.32M Shares Change (YoY) 0.44% Shares Change (QoQ) 0.18% Owned by Institutions (%) 72.07% Shares Floating 115.47M Failed to Deliver (FTD) Shares 4,271 FTD / Avg. Volume 2.33%
Short Selling Information The latest short interest is 23.02K, so 0.02% of the outstanding
shares have been sold short.
Short Interest 23.02K Short % of Shares Out 0.02% Short % of Float 0.05% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -3.6 and the forward
PE ratio is -31.
Xtant Medical's PEG ratio is
0.
PE Ratio -3.6 Forward PE -31 PS Ratio 0.5 Forward PS 0.6 PB Ratio 1.38 P/FCF Ratio -3.7 PEG Ratio 0
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Xtant Medical.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 2.35,
with a Debt / Equity ratio of 0.82.
Current Ratio 2.35 Quick Ratio 1 Debt / Equity 0.82 Debt / EBITDA -4.46 Debt / FCF -2.2 Interest Coverage -2.9
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $540.4K Profits Per Employee $-75.8K Employee Count 217 Asset Turnover 1.25 Inventory Turnover 1.27
Taxes Income Tax 187K Effective Tax Rate -1.15%
Stock Price Statistics The stock price has increased by -6.71% in the
last 52 weeks. The beta is -0.22, so Xtant Medical's
price volatility has been lower than the market average.
Beta -0.22 52-Week Price Change -6.71% 50-Day Moving Average 0.64 200-Day Moving Average 0.53 Relative Strength Index (RSI) 51.53 Average Volume (20 Days) 183,209
Income Statement In the last 12 months, Xtant Medical had revenue of 117.27M
and earned -16.45M
in profits. Earnings per share was -0.12.
Revenue 117.27M Gross Profit 68.22M Operating Income -12.07M Net Income -16.45M EBITDA -7.88M EBIT -12.1M Earnings Per Share (EPS) -0.12
Full Income Statement Balance Sheet The company has 6.2M in cash and 35.14M in
debt, giving a net cash position of -28.94M.
Cash & Cash Equivalents 6.2M Total Debt 35.14M Net Cash -28.94M Retained Earnings -259.46M Total Assets 95.83M Working Capital 39.56M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -11.9M
and capital expenditures -4.11M, giving a free cash flow of -16.01M.
Operating Cash Flow -11.9M Capital Expenditures -4.11M Free Cash Flow -16.01M FCF Per Share -0.12
Full Cash Flow Statement Margins Gross margin is 58.17%, with operating and profit margins of -10.3% and -14.03%.
Gross Margin 58.17% Operating Margin -10.3% Pretax Margin -13.87% Profit Margin -14.03% EBITDA Margin -6.72% EBIT Margin -10.3% FCF Margin -13.65%
Dividends & Yields XTNT does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for XTNT is $3,
which is 426.3% higher than the current price. The consensus rating is "Strong Buy".
Price Target $3 Price Target Difference 426.3% Analyst Consensus Strong Buy Analyst Count 1
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Feb 14, 2018. It was a
backward
split with a ratio of 1:12.
Last Split Date Feb 14, 2018 Split Type backward Split Ratio 1:12
Scores Altman Z-Score -1.28 Piotroski F-Score 2
